About this trial
The proposed multimodal telerehabilitation model allows a rehabilitation therapy team to set up individualized rehabilitation plans using a web-based care management portal and monitor patient progress online. Patients at home follow a safe and effective personalized exercise and nutrition plan guided by interactive touch-screen technology combined with behavioral counseling, social support, and interactive education and empowerment. The design of the telerehabilitation system is based on the cloud-based Internet-of-Things architecture allowing real-time monitoring of cardiovascular parameters and exercise performance. The patient's level of exertion during exercise is automatically identified by a validated AI-driven algorithm supporting exercise safety and efficacy. The ultimate goal of this pilot feasibility project is to establish the extent of the impact of the proposed patient-centered cancer telerehabilitation model on disease-specific quality of life, and functional and symptom outcomes and to obtain sufficient evidence for a definitive randomized clinical trial evaluating this approach in a multi-center study.
Eligibility criteria
Qualifiers
age >21
confirmed diagnosis of lymphoma or myeloma
commercial FDA-approved CAR-T delivery planned for ≥4 weeks following enrollment
Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
Disqualifiers
have unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers, painful or unstable bony metastases, or recent skeletal fractures;
are engaged in a regular exercise rehabilitation program;
have relocation plans within next 6 months;
participate in another clinical trial.
Trial design
Treatments tested in this trial
- Home Automated Telemanagement (HAT) Patient Unit
Treatment groups
Sponsors and collaborators
University of Utah
Lead sponsor
United States Department of Defense
Collaborator